Rankings
▼
Calendar
FOLD FY 2011 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
FY 2011 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$21M
+2224.7% YoY
Gross Profit
$21M
100.0% margin
Operating Income
-$51M
-237.4% margin
Net Income
-$44M
-207.2% margin
EPS (Diluted)
$-1.28
Cash Flow
Operating Cash Flow
-$49M
Free Cash Flow
-$51M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$70M
Total Liabilities
$40M
Stockholders' Equity
$30M
Cash & Equivalents
$26M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$21M
$922,000
+2224.7%
Gross Profit
$21M
$922,000
+2224.7%
Operating Income
-$51M
-$56M
+8.9%
Net Income
-$44M
-$55M
+19.2%
← FY 2010
All Quarters
FY 2012 →